Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Lupus & Connective Tissue Diseases

  • News

    Tocilizumab shortage continues as pandemic wears on

    August 19, 2021

    Emergency use authorization of tocilizumab for COVID-19 has led to a global shortage, but supplies for rheumatoid arthritis and other inflammatory conditions are faring better – for now.

  • News

    COVID-19’s impact on lupus inpatients examined in study

    March 24, 2021

    Younger inpatients with COVID-19 and SLE showed higher mortality than did COVID-19 inpatients of similar age from the general population in a French epidemiologic study.

  • 1
    News

    Rheumatologic disease activity an important influencer of COVID-19 death risk

    February 5, 2021

    COVID-19 Global Rheumatology Alliance physician registry data highlight need to maintain adequate disease control to lower risk for death from COVID-19.

  • 1
    News

    COVID-19 risks in rheumatic disease remain unclear

    November 7, 2020

    Elevated COVID-19-related risks, many associated with comorbidities, emerged in a match-control study, whereas a systematic review delivers more encouraging news for people living with rheumatic disease.

  • News

    COVID-19–related HCQ shortages affected rheumatology patients worldwide

    November 6, 2020

    Data from the Global Rheumatology Alliance Patient Experience Survey presented at ACR Convergence 2020 demonstrate that the severity of shortages differed widely across the globe.

  • 1
    News

    Even a few days of steroids may be risky, new study suggests

    July 9, 2020

    A retrospective study of more than 2.6 million Taiwanese adults echoes findings from a 2017 cohort study of more than 1.5 million U.S. adults.

  • 1
    News

    ACIP approves flu vaccine recommendations for 2020-2021

    June 25, 2020

    Next season’s vaccination options include new high-dose quadrivalent vaccines for seniors.

  • 1
    News

    EULAR’s COVID-19 recommendations offer no surprises

    June 11, 2020

    The provisional recommendations cover four themes: general measures and preventing SARS-CoV-2 infection, managing patients without COVID-19 and those with the infection, and preventing COVID-19 lookalikes.

  • 1
    News

    Age leads COVID-19 hospitalization risk factors in RMDs

    June 10, 2020

    Glucocorticoid use, cardiovascular comorbidity, and male gender were also found to increase the risk of hospitalization from COVID-19 in inflammatory rheumatic diseases.

  • 1
    News

    Most rheumatology drugs don’t increase COVID-19 hospitalization risk

    June 4, 2020

    “These results provide, for the first time, information about the outcome of COVID-19 in patients with rheumatic and musculoskeletal diseases.”

1 2 3Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences